Craneware (LON:CRW) Share Price Passes Below 200-Day Moving Average - Should You Sell?

Craneware plc (LON:CRW - Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 2,224.75 ($28.04) and traded as low as GBX 2,200 ($27.73). Craneware shares last traded at GBX 2,230 ($28.10), with a volume of 38,643 shares.

Analyst Upgrades and Downgrades

Separately, Berenberg Bank reiterated a "buy" rating and issued a GBX 2,700 ($34.03) price target on shares of Craneware in a research note on Tuesday, September 3rd.

Craneware Stock Down 1.8 %

The firm has a 50-day simple moving average of GBX 2,066.67 and a two-hundred day simple moving average of GBX 2,225.09. The stock has a market cap of £788.08 million, a P/E ratio of 8,576.92 and a beta of 0.28. The company has a current ratio of 0.63, a quick ratio of 1.00 and a debt-to-equity ratio of 12.22.

Craneware Increases Dividend

The business also recently declared a dividend, which will be paid on Wednesday, December 18th. Investors of record on Thursday, November 28th will be given a dividend of GBX 16 ($0.20) per share. The ex-dividend date of this dividend is Thursday, November 28th. This represents a yield of 0.77%. This is an increase from Craneware's previous dividend of $13.00. Craneware's dividend payout ratio is currently 11,153.85%.

Insider Buying and Selling

In other Craneware news, insider Keith Neilson sold 423,750 shares of the firm's stock in a transaction that occurred on Wednesday, September 11th. The shares were sold at an average price of GBX 2,200 ($27.73), for a total value of £9,322,500 ($11,748,582.23). 19.28% of the stock is owned by company insiders.

About Craneware

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors.